COREV 2.0 PMCF-Study on Manual and Navigated Revision Knee Patients
COREV
Comparative, Case Control, Mono-center PMCF Study on Manual and Navigated Revision Knee Patients After a Minimum Follow-Up of Two Years
1 other identifier
observational
100
1 country
1
Brief Summary
The Columbus® Revision endoprosthetic system is bearing the CE-mark. This means that within the scope of this observational study the patient will not be subjected to any additional stressful, study-related medical examinations or treatment measures. The treatment will be carried out exclusively according to medical standards. The study therefore only serves the purpose of observing this standard-compliant treatment and specifically documenting it scientifically.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 11, 2021
CompletedFirst Posted
Study publicly available on registry
November 9, 2021
CompletedStudy Start
First participant enrolled
March 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 24, 2024
CompletedAugust 14, 2025
August 1, 2025
1.3 years
October 11, 2021
August 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compare the final joint line height between groups after the surgical restoration of native joint line height of revision implants
Joint line height will be assessed using the systematic, comparative x-ray analysis
Comparison of final joint line height before the surgery with height at the 3 months follow-up
Secondary Outcomes (6)
Maintenance of Hip knee Ankle Angle
Comparison of HKA before the surgery with HKA at 3 months and 2 years follow-up
Forgotten Joint Score
At final follow-up at least 2 years after surgery
WOMAC Score
At final follow-up at least 2 years after surgery
KSS Score
At final follow-up at least 2 years after surgery
Implant survival
Until final follow-up at least 2 years after surgery
- +1 more secondary outcomes
Other Outcomes (1)
Descriptive analysis of Radiological assessment
from discharge until final follow-up at least 2 years after surgery
Study Arms (2)
navigation assisted knee revision surgery
manual procedure
Interventions
Patients in the case group receive a Columbus® Revision knee prosthesis, implanted with computer assisted surgery
Patients in the control group will correspond to a historical cohort of patients in which manual jig-assisted knee revision was done.
Eligibility Criteria
Patients in the case group will be recruited consecutively. No selection besides the inclusion and exclusion criteria will take place. The following criteria are applicable for the inclusion of study patients: Patients in the control group will correspond to a historical cohort of patients in which manual jig-assisted knee revision was done. A minimum of two years follow up will be necessary to be included.
You may qualify if:
- Patient underwent navigated revision surgery using the Columbus® Revision knee prosthesis (case group)
- Patient underwent conventional manual revision surgery using another implant system (control group)
- Written informed consent
You may not qualify if:
- Pregnancy
- Patient Age at time of revision surgery \< 18 years
- Allergy to any prosthesis component
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aesculap AGlead
- B.Braun Surgical SAcollaborator
Study Sites (1)
Hospital Universitario Cruces
Barakaldo, Bizkaia, 48903, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emilio Larrazabal Raluy, MD
Hospital Universitario Cruces, Spain
- PRINCIPAL INVESTIGATOR
Igor Gonzales, MD
Hospital Universitario Cruces, Spain
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 11, 2021
First Posted
November 9, 2021
Study Start
March 16, 2022
Primary Completion
June 16, 2023
Study Completion
March 24, 2024
Last Updated
August 14, 2025
Record last verified: 2025-08